Cordis Corporation clinical trials
The registry lists 78 studies whose lead sponsor is Cordis Corporation. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 2, 2026.
Our grouping of 2 registry names, not the registry’s. See them and correct one ↓
- 78studies on the registry
- 2open to participants now
Get an email when these change. Save the Cordis Corporation studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
What it is testing
The drugs Cordis Corporation’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
All 78 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 07
- 608
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 226
By the year each study started; 50 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Cordis Corporation.
- Cordis Corporation70 studiesSame company
Something wrong?
- Cordis US Corp.8 studiesSame company
Something wrong?
Focus areas
Conditions Cordis Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 78. Browse all 78 →
- Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery StenosisRecruitingNCT07122518
Sponsor listed in the registry: Cordis US Corp.
- Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery DiseaseNot yet recruitingNCT07338890
Sponsor listed in the registry: Cordis US Corp.
- Mobilization and Outcomes After Venous ClosureCompletedNCT07246902
Sponsor listed in the registry: Cordis US Corp.
- Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure DeviceCompletedNCT03923387Not applicable
Sponsor listed in the registry: Cordis US Corp.
- PMCF Study of Precise Pro Rx for Carotid Artery DiseaseCompletedNCT07204678
Sponsor listed in the registry: Cordis US Corp.
- Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial AccessCompletedNCT05399680Not applicable
Sponsor listed in the registry: Cordis US Corp.
- Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual CompressionCompletedNCT05554471Not applicable
- A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)CompletedNCT01664078Not applicable
Sponsor listed in the registry: Cordis US Corp.
- European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic AneurysmsCompletedNCT02477111
Sponsor listed in the registry: Cordis US Corp.
- PMCF Study for Cardiology Access ProceduresCompletedNCT05543096
- PMCF Study for Peripheral Arteries Above the Knee (ATK)CompletedNCT05312580
- PMCF Study for Peripheral Arteries Below the Knee (BTK)CompletedNCT05444660
- A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)CompletedNCT01106391Not applicable
- China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)WithdrawnNCT03965364
- SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for EndarterectomyCompletedNCT00403078
- Compassionate Use of the Incraft® AAA Stent Graft SystemNo longer availableNCT01776450
- Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent SystemCompletedNCT01355406Not applicable
- S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery DiseaseCompletedNCT00739102Not applicable
- CYPRESS - CYPHER for Evaluating Sustained SafetyStatus unknownNCT00954707Phase 4
- Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent SystemsStatus unknownNCT00715884Not applicable
- A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)CompletedNCT00322569Phase 3
- An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)TerminatedNCT01202058Phase 3
- Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery LesionsTerminatedNCT00714883Phase 2
- Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery LesionsTerminatedNCT00606333Not applicable
- Safety and Effectiveness Study of the Ensure Medical Vascular Closure DeviceCompletedNCT00345631Phase 3
- ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EUCompletedNCT00574691Phase 1
- Plug Arterial Closure System (PACS, 7F)CompletedNCT00533156Phase 2
- Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)CompletedNCT00165035Phase 3
- Cynergy: the CYPHER-NEVO RegistryTerminatedNCT01106378
- Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial DiseaseCompletedNCT00640770Phase 4
- French Post-Marketing Surveillance SurveyTerminatedNCT00855478Phase 4
- The Intra-Drug Eluting Stent (DES) Restenosis StudyCompletedNCT00323895Phase 4
- A Study of the Presillion Stent in de Novo Coronary LesionsCompletedNCT00722579Phase 3
- The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)CompletedNCT00974181Phase 3
- NEXUS Study for the Treatment of de Novo Native Coronary Artery LesionsCompletedNCT00231283Phase 3
- Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232739Phase 3
- The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ StentCompletedNCT00235131Phase 4
- Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis TrialCompletedNCT00497172Phase 4
- The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.CompletedNCT00749424Phase 4
- A Study of the SMART Stent in the Treatment SFA Disease.CompletedNCT00232869Phase 2
- Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)CompletedNCT00231244Phase 3
- A Multi-center Post-Market Surveillance RegistryCompletedNCT00438919Phase 4
- A Study of Diabetic Patients With De Novo Native Coronary Artery LesionsCompletedNCT00495898Phase 4
- Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232752Phase 3
- Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)CompletedNCT00231257Phase 3
- Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery LesionsCompletedNCT00233714Phase 1/2
- The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)CompletedNCT00403338
- Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)CompletedNCT00232765Phase 3
- The Study to Assess AMI Treated With Balloon Angioplasty.CompletedNCT00232830Phase 3
- The Study to Compare SMART Nitinol Stent and Balloon AngioplastyCompletedNCT00309595Phase 4